India to Canada: Lenalidomide Export Trade Route
India has recorded 16 verified shipments of Lenalidomide exported to Canada, representing a combined trade value of $3.8M USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $235.9K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 86% of total export value with 9 shipments worth $3.2M USD. On the buying side, TARO PHARMACEUTICALS INC., is the largest importer in Canada with $966.5K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, NATCO PHARMA LIMITED , DR REDDY S LABORATORIES LIMITED — together control 96% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Canada Lenalidomide corridor is one of India's established pharmaceutical export routes, with 16 shipments documented worth a combined $3.8M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 86% of all export value, reflecting the consolidated nature of India's lenalidomide manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $235.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 31.0%, placing it at rank #15 among India's top lenalidomide export destinations globally.
On the import side, key buyers of Indian lenalidomide in Canada include TARO PHARMACEUTICALS INC.,, TARO PHARMACEUTICALS INC, TARO PHARMACEUTICALS INC. and 6 others. TARO PHARMACEUTICALS INC., is the single largest importer with 3 shipments valued at $966.5K USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portSAHAR AIR
Market Position
- Global rank#15
- Annual growth+31.0%
- Demand growth+25.9%
- Regulatory ease69/100
Top 10 Indian Lenalidomide Exporters to Canada
Showing top 10 of 4 Indian suppliers exporting Lenalidomide to Canada, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $358.8K per shipment | 9 | $3.2M | 85.6% |
| 2 | NATCO PHARMA LIMITED Avg $78.2K per shipment | 3 | $234.6K | 6.2% |
| 3 | DR REDDY S LABORATORIES LIMITED Avg $77.6K per shipment | 2 | $155.1K | 4.1% |
| 4 | DR REDDYS LABORATORIES LIMITED Avg $77.5K per shipment | 2 | $154.9K | 4.1% |
This table shows the top 10 of 4 Indian companies exporting lenalidomide to Canada, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, NATCO PHARMA LIMITED , DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 9 shipments worth $3.2M USD, giving it a 86% market share. The top 3 suppliers together account for 96% of the total trade value on this route.
Top 10 Lenalidomide Importers in Canada
Showing top 10 of 9 known buyers in Canada receiving Lenalidomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian lenalidomide in Canada include TARO PHARMACEUTICALS INC.,, TARO PHARMACEUTICALS INC, TARO PHARMACEUTICALS INC., M/S TARO PHARMACEUTICALS INC.,, NATCO PHARMA (CANADA) INC , among 9 total buyers. The largest importer is TARO PHARMACEUTICALS INC.,, accounting for $966.5K USD across 3 shipments — representing 26% of all lenalidomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TARO PHARMACEUTICALS INC., | 3 | $966.5K | 25.6% |
| 2 | TARO PHARMACEUTICALS INC | 2 | $966.0K | 25.6% |
| 3 | TARO PHARMACEUTICALS INC. | 3 | $949.1K | 25.1% |
| 4 | M/S TARO PHARMACEUTICALS INC., | 1 | $347.8K | 9.2% |
| 5 | NATCO PHARMA (CANADA) INC | 3 | $234.6K | 6.2% |
| 6 | XX RXXDY XXLABXXATOXXES XXNADXXINC | 1 | $109.7K | 2.9% |
| 7 | Dr Reddy s Laboratories Canada Incv | 1 | $109.6K | 2.9% |
| 8 | XX RXXDYSXXABOXXTORXXS CXXADAXXNC | 1 | $45.5K | 1.2% |
| 9 | DR REDDYS LABORATORIES CANADA INC | 1 | $45.4K | 1.2% |
Top 10 Lenalidomide Formulations Imported by Canada
Showing top 10 of 15 product formulations shipped on the India to Canada Lenalidomide route, ranked by trade value
Canada imports a wide range of lenalidomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — TARO-LENALIDOMIDE CAPSULES 10MG (342 PACK X 4X7) (BATCH NO. HAF2787C MFG DT. 11/2024 EXP DT. 10/2026) — accounts for $716.9K USD across 2 shipments. There are 15 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TARO-LENALIDOMIDE CAPSULES 10MG (342 PACK X 4X7) (BATCH NO. HAF2787C MFG DT. 11/2024 EXP DT. 10/2026) | 2 | $716.9K | 19.0% |
| 2 | TARO-LENALIDOMIDE CAP 10 MG 4X7's CANADA | 1 | $597.6K | 15.8% |
| 3 | TARO-LENALIDOMIDE CAP20MG3X7S (PACK 3X7S) BATCH NO. AS PER INVOICE.NOS | 1 | $458.6K | 12.2% |
| 4 | TARO-LENALIDOMIDE CAP 5MG 4X7S (PACK 04*07) BATCH NO. AS PER INVOICE.NOS | 1 | $433.8K | 11.5% |
| 5 | TARO-LENALIDOMIDE CAP15MG3X7S CANADA | 1 | $368.3K | 9.8% |
| 6 | TARO-LENALIDOMIDE CAP 5MG 4X7S CANADA PACK : 04*07 Batch : HAG0123C | 1 | $347.8K | 9.2% |
| 7 | TARO-LENALIDOMIDE CAPSULES 2.5MG [492 PACK X 3X7'S]NOS | 1 | $232.2K | 6.2% |
| 8 | NAT-LENALIDOMIDE 10MG CAPSULES 28'S (OTH | 1 | $167.1K | 4.4% |
| 9 | REDDY-LENALIDOMIDECAP15MG 21(3X7S)CANADA | 1 | $109.7K | 2.9% |
| 10 | REDDY-LENALIDOMIDECAP15MG 213X7SCANADA | 1 | $109.6K | 2.9% |
Showing top 10 of 15 Lenalidomide formulations imported by Canada on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
SAHAR AIR handles the highest volume with 5 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's lenalidomide exports to Canada are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, NATCO PHARMA LIMITED , DR REDDY S LABORATORIES LIMITED — together account for 96% of total trade value on this route. The average shipment value of $235.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as taro-lenalidomide cap 10 mg 4x7's canada and taro-lenalidomide cap20mg3x7s (pack 3x7s) batch no. as per invoice.nos, suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TARO PHARMACEUTICALS INC., is the largest importer with 3 shipments worth $966.5K USD — representing 26% of all lenalidomide imports from India on this route. A total of 9 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $3.8M
- Avg. Shipment
- $235.9K
- Suppliers
- 4
- Buyers
- 9
- Transit (Sea)
- ~27 days
- Annual Growth
- +31.0%
Related Analysis
Other Lenalidomide Routes
Unlock the Full India to Canada Lenalidomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 16 shipments on this route.
Frequently Asked Questions — India to Canada Lenalidomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Lenalidomide to Canada?
The leading Indian exporters of Lenalidomide to Canada are SUN PHARMACEUTICAL INDUSTRIES LIMITED, NATCO PHARMA LIMITED , DR REDDY S LABORATORIES LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 86% of total trade value on this route.
Q What is the total value of Lenalidomide exports from India to Canada?
India exports Lenalidomide to Canada worth approximately $3.8M USD across 16 recorded shipments. The average value per shipment is $235.9K USD.
Q Which ports does India use to ship Lenalidomide to Canada?
The most active port of origin is SAHAR AIR with 5 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Canada for Lenalidomide?
The average transit time for Lenalidomide shipments from India to Canada is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Canada Lenalidomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 31.0% with demand growth tracking at 25.9%. The route is ranked #15 among India's top Lenalidomide export destinations globally.
Q How many suppliers are active on the India to Canada Lenalidomide route?
There are currently 4 active Indian suppliers exporting Lenalidomide to Canada. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 86% of total shipment value.
Q Who are the main importers of Lenalidomide from India in Canada?
The leading importers of Indian Lenalidomide in Canada include TARO PHARMACEUTICALS INC.,, TARO PHARMACEUTICALS INC, TARO PHARMACEUTICALS INC., M/S TARO PHARMACEUTICALS INC.,, NATCO PHARMA (CANADA) INC . TARO PHARMACEUTICALS INC., is the largest buyer with 3 shipments worth $966.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Canada export trade corridor identified from Indian Customs (DGFT) records for Lenalidomide.
- 2.Supplier/Buyer Matching: 4 Indian exporters and 9 importers in Canada matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 16 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
16 Verified Shipments
4 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists